Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

Alterations in Muscle Tone ll

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

Disorders of the Nervous Tissue

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Journal for immunotherapy of cancer·2026

Same author

Isolated Peripheral Nervous System Presentation in Ma/Ma2-Associated Autoimmunity.

Neurology(R) neuroimmunology & neuroinflammation·2026

Same author

Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome.

Breast cancer research : BCR·2026

Same author

Alternative diagnoses of suspected paraneoplastic neurological syndromes: a population-based study.

Journal of neurology·2026

Same author

Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Neurology(R) neuroimmunology & neuroinflammation·2026

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Paraneoplastic neurological syndromes.

Jérôme Honnorat¹, Jean-Christophe Antoine

¹Inserm U 842, Université Claude Bernard Lyon 1, Lyon, France. jerome.honnorat@chu-lyon.fr

Orphanet Journal of Rare Diseases

|May 8, 2007

Summary

Paraneoplastic neurological syndromes (PNS) are rare autoimmune disorders triggered by cancer, affecting the nervous system. Early diagnosis via anti-onconeural antibodies aids cancer detection and treatment, improving patient outcomes.

Area of Science:

Neurology
Oncology
Immunology

Background:

Paraneoplastic neurological syndromes (PNS) are rare autoimmune conditions triggered by cancer, affecting the nervous system.
PNS manifest as remote effects of cancer, distinct from metastasis or metabolic issues, impacting nerves, muscles, and the neuromuscular junction.
Neurological symptoms often precede cancer diagnosis, necessitating neurologist identification of PNS.

Purpose of the Study:

To define Paraneoplastic Neurological Syndromes (PNS) and their clinical significance.
To highlight the diagnostic role of anti-onconeural antibodies in identifying underlying cancers.
To discuss treatment strategies focusing on cancer management and immune suppression.

Main Methods:

Review of existing literature on PNS.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jul 15, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Analysis of diagnostic criteria for PNS.

Discussion of the role of onconeural antigens and associated antibodies in diagnosis and cancer detection.

Main Results:

PNS are diverse, affecting various nervous system components, with Lambert-Eaton myasthenic syndrome being relatively common in small cell lung cancer.
Detection of specific anti-onconeural antibodies offers high diagnostic accuracy (>90%) for PNS and can guide early cancer detection.
A significant minority of patients lack detectable or have atypical antibodies, posing diagnostic challenges.

Conclusions:

Identifying anti-onconeural antibodies is crucial for diagnosing PNS and detecting occult cancers.
Prompt cancer treatment is the primary strategy for stabilizing PNS.
Immune suppression is a key therapeutic approach for these immune-mediated disorders.